Stocks and Investing Stocks and Investing
Tue, February 28, 2017

John Eade Downgraded (TEVA) to Hold on, Feb 28th, 2017


Published on 2024-10-25 20:21:52 - WOPRAI, John Eade
  Print publication without navigation


John Eade of Argus Research, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Feb 28th, 2017.

John has made no other calls on TEVA in the last 4 months.



There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 4 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, January 20th, 2017
  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $42 on, Wednesday, November 16th, 2016
  • Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, November 16th, 2016
  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016


These are the ratings of the 3 analyists that currently disagree with John


  • Irina Rivkind Koffler of "Mizuho" Downgraded from Hold to Sell and Decreased Target to $27 on, Friday, February 10th, 2017
  • Sumant Kulkarni of "B of A Securities" Upgraded from Hold to Strong Buy on, Tuesday, January 31st, 2017
  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016

Contributing Sources